Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Asset Utilization Ratio: 2013-2023

Historic Asset Utilization Ratio for RedHill Biopharma (RDHL) over the last 10 years, with Jun 2023 value amounting to 0.76.

  • RedHill Biopharma's Asset Utilization Ratio rose 69.80% to 0.76 in Q2 2023 from the same period last year, while for Jun 2023 it was 0.76, marking a year-over-year increase of 69.80%. This contributed to the annual value of 0.39 for FY2024, which is 445.31% up from last year.
  • According to the latest figures from Q2 2023, RedHill Biopharma's Asset Utilization Ratio is 0.76, which was up 58.52% from 0.48 recorded in Q1 2023.
  • In the past 5 years, RedHill Biopharma's Asset Utilization Ratio registered a high of 0.76 during Q2 2023, and its lowest value of 0.05 during Q1 2020.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.47 (2021), whereas its average is 0.50.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 59.38% in 2020, then spiked by 920.21% in 2021.
  • Quarterly analysis of 5 years shows RedHill Biopharma's Asset Utilization Ratio stood at 0.11 in 2019, then soared by 346.54% to 0.49 in 2020, then decreased by 5.02% to 0.47 in 2021, then fell by 16.20% to 0.39 in 2022, then skyrocketed by 69.80% to 0.76 in 2023.
  • Its last three reported values are 0.76 in Q2 2023, 0.48 for Q1 2023, and 0.39 during Q4 2022.